Assignee
RHYTHM PHARMACEUTICALS INC
US·9 granted patents·11 pending applications·18 citations·filing 2014–2025
Top patents by PatentIndex Score
20 records- 0190US12285460B2Pharmaceutical compositionsRHYTHM PHARMACEUTICALS INC·Filed 2021·Granted Apr 29, 2025·1 cites·11 claims
- 0288US11129869B2Pharmaceutical compositionsRHYTHM PHARMACEUTICALS INC·Filed 2014·Granted Sep 28, 2021·5 cites·24 claims
- 0386US10954268B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2019·Granted Mar 23, 2021·1 cites·18 claims
- 0486US10858399B2Peptide compositionsRHYTHM PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·2 cites·20 claims
- 0586US10196425B2Peptide compositionsRHYTHM PHARMACEUTICALS INC·Filed 2014·Granted Feb 5, 2019·7 cites·27 claims
- 0684US2025188124A1Peptide compositionsRHYTHM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0784US2024190914A1Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0882US10167312B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2017·Granted Jan 1, 2019·2 cites·14 claims
- 0980US2025195606A1Method of treating melanocortin-4 receptor pathway-associated disordersRHYTHM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1077US2022226425A1Method of treating melanocortin-4 receptor pathway-associated disordersRHYTHM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1176US11702448B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 1274US2025186536A1Sustained release peptide formulationsRHYTHM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1372US12077612B2Peptide compositionsRHYTHM PHARMACEUTICALS INC·Filed 2020·Granted Sep 3, 2024·0 cites·6 claims
- 1472US2026053885A1Pharmaceutical compositionsRHYTHM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1570US2025082717A1Compositions for treating kidney diseaseRHYTHM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1664US2025360142A1Novel atp-sensitive potassium channel potentiators, their preparation and useRHYTHM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1758US2021169965A1Sustained release peptide formulationsRHYTHM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1854US10960046B2Method of treating melanocortin-4 receptor pathway-associated disordersRHYTHM PHARMACEUTICALS INC·Filed 2016·Granted Mar 30, 2021·0 cites·8 claims
- 1946US2024058414A1Methods of treating melanocortin-4 receptor pathway-associated disordersRHYTHM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2045US2026001915A1Methods for treating obesity with an mc4r agonistRHYTHM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RHYTHM PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →